Genzyme 2Q profit drops on charges, lower sales – The Associated Press
By Dr. Matthew Watson
 RTT News | Genzyme 2Q profit drops on charges, lower sales The Associated Press Biotechnology company Genzyme Corp. said Wednesday its profit shrank drastically in the second quarter because of falling sales and charges partly connected ... Genzyme Q2 Profit Plunges On Supply Constraints; Cuts Full-year OutlookRTT News Genzyme stays in blackWorcester Telegram Genzyme Profit Tiny On Quarterly Revenue DipWorcester Business Journal TradersHuddle.com -Mass High Tech -Stock Markets Review all 105 news articles » |
Uncategorized
Comments Off on Genzyme 2Q profit drops on charges, lower sales – The Associated Press |
July 22nd, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research